Seguir
Timothy A. Lin
Timothy A. Lin
Department of Radiation Oncology and Molecular Radiation Sciences, Johns Hopkins University School
Dirección de correo verificada de jh.edu
Título
Citado por
Citado por
Año
Factors associated with age disparities among cancer clinical trial participants
EB Ludmir, W Mainwaring, TA Lin, AB Miller, A Jethanandani, ...
JAMA oncology 5 (12), 1769-1773, 2019
1912019
Exploring applications of radiomics in magnetic resonance imaging of head and neck cancer: a systematic review
A Jethanandani, TA Lin, S Volpe, H Elhalawani, ASR Mohamed, P Yang, ...
Frontiers in oncology 8, 131, 2018
912018
Machine learning applications in head and neck radiation oncology: lessons from open-source radiomics challenges
H Elhalawani, TA Lin, S Volpe, ASR Mohamed, AL White, J Zafereo, ...
Frontiers in oncology 8, 294, 2018
42*2018
Racial and ethnic disparities among participants in US-based phase 3 randomized cancer clinical trials
SR Grant, TA Lin, AB Miller, W Mainwaring, AF Espinoza, A Jethanandani, ...
JNCI Cancer Spectrum 4 (5), pkaa060, 2020
402020
Progression-free survival is a suboptimal predictor for overall survival among metastatic solid tumour clinical trials
D Pasalic, GJ McGinnis, CD Fuller, AJ Grossberg, V Verma, ...
European Journal of Cancer 136, 176-185, 2020
392020
Tobacco exposure as a major modifier of oncologic outcomes in human papillomavirus (HPV) associated oropharyngeal squamous cell carcinoma
H Elhalawani, ASR Mohamed, B Elgohari, TA Lin, AG Sikora, SY Lai, ...
BMC cancer 20, 1-12, 2020
322020
Differences between planned and delivered dose for head and neck cancer, and their consequences for normal tissue complication probability and treatment adaptation
J Heukelom, ME Kantor, ASR Mohamed, H Elhalawani, E Kocak-Uzel, ...
Radiotherapy and Oncology 142, 100-106, 2020
312020
Women’s representation among lead investigators of clinical trials in oncology
EB Ludmir, W Mainwaring, AB Miller, TA Lin, A Jethanandani, ...
JAMA oncology 5 (10), 1501-1502, 2019
292019
Decreasing incidence of upper age restriction enrollment criteria among cancer clinical trials
EB Ludmir, IM Subbiah, W Mainwaring, AB Miller, TA Lin, A Jethanandani, ...
Journal of geriatric oncology 11 (3), 451-454, 2020
282020
Radiographic retropharyngeal lymph node involvement in HPV‐associated oropharyngeal carcinoma: patterns of involvement and impact on patient outcomes
TA Lin, AS Garden, H Elhalawani, B Elgohari, A Jethanandani, SP Ng, ...
Cancer 125 (9), 1536-1546, 2019
232019
Exclusion of patients with brain metastases from cancer clinical trials
RR Patel, V Verma, AB Miller, TA Lin, A Jethanandani, AF Espinoza, ...
Neuro-oncology 22 (4), 577-579, 2020
222020
Timing of local therapy affects survival in Ewing sarcoma
TA Lin, EB Ludmir, KP Liao, MF McAleer, DR Grosshans, SL McGovern, ...
International Journal of Radiation Oncology* Biology* Physics 104 (1), 127-136, 2019
212019
Performance status restriction in phase III cancer clinical trials
J Abi Jaoude, R Kouzy, W Mainwaring, TA Lin, AB Miller, A Jethanandani, ...
Journal of the National Comprehensive Cancer Network 18 (10), 1322-1326, 2020
202020
Exclusion of men from randomized phase III breast cancer clinical trials
KL Corrigan, W Mainwaring, AB Miller, TA Lin, A Jethanandani, ...
The Oncologist 25 (6), e990-e992, 2020
202020
Sex-based disparities among cancer clinical trial participants
EB Ludmir, CD Fuller, S Moningi, W Mainwaring, TA Lin, AB Miller, ...
JNCI: Journal of the National Cancer Institute 112 (2), 211-213, 2020
142020
Stereotactic body radiation therapy in primary hepatocellular carcinoma: current status and future directions
TA Lin, JS Lin, T Wagner, N Pham
Journal of gastrointestinal oncology 9 (5), 858, 2018
132018
Exclusion of older adults in COVID-19 clinical trials
J Abi Jaoude, R Kouzy, MB El Alam, V Subbiah, CM Taniguchi, EB Ludmir, ...
Mayo Clinic Proceedings 95 (10), 2293, 2020
122020
Reporting and exclusion of sexual and gender minorities in cancer clinical trials.
EB Ludmir, AF Espinoza, A Jethanandani, TA Lin, W Mainwaring, ...
International journal of cancer 146 (8), 2020
122020
Food and Drug Administration approvals in phase 3 cancer clinical trials
J Abi Jaoude, R Kouzy, M Ghabach, R Patel, D Pasalic, E Ghossain, ...
BMC cancer 21 (1), 695, 2021
112021
Non-English language validation of patient-reported outcome measures in cancer clinical trials
SR Grant, SS Noticewala, W Mainwaring, TA Lin, AB Miller, ...
Supportive Care in Cancer 28, 2503-2505, 2020
112020
El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.
Artículos 1–20